This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Becker HF, Mayer G, Penzel T (2004): Schlafstörungen und schlafbezogene Atmungsstörungen. Internist 45: 57–81.
Black JE, Brooks SN, Nishino S (2004): Narcolepsy and syndromes of primary excessive daytime somnolence. Semin Neurol 24: 271–282.
Clarenbach P, Steinberg R, Weeß HG, Berger M, Hajak G et al (1995): Empfehlungen zu Diagnostik und Therapie der Insomnie. Deutsche Gesellschaft für Schlafforschung und Schlafmedizin DGSM. Nervenarzt 66: 723–729.
Crestani F, Martin JR, Möhler H, Rudolph U (2000): Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 131: 1251–1254.
Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I (2000): Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 33: 47–53.
Dooley M, Plosker GL (2000): Zaleplon: a review of its use in the treatment of insomnia. Drugs 60: 413–445.
Englert S, Linden M (1998): Differences in self-reported sleep complaints in elderly persons living in the community who do or do not take sleep medication. J Clin Psychiatry 59: 137–144.
Garcia-Borreguero D, Odin P, Schwarz C (2004): Restless legs syndrome: an overview of the current understanding and management. Acta Neurol Scand 109: 303–317.
Glass JR, Sproule BA, Herrmann N, Streiner D, Busto UE (2003): Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects. J Clin Psychopharmacol 23: 260–268.
Hänsel R (1987): Möglichkeiten und Grenzen pflanzlicher Arzneimittel (Phytotherapie). Dtsch Apoth Ztg 127: 2–6.
Hänsel R, Volz HP (1995): Pflanzliche Mittel mit psychotroper Wirkung. In: Riederer P, Laux, G, Pöldinger, W (Hrsg): Neuropsychopharmaka, Bd 2, Springer-Verlag, Wien, S. 303–334.
Hajak G, Müller WE, Wittchen HU, Pittrow D, Kirch W (2003): Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98: 1371–1378.
Happe S (2003): Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management. Drugs 63: 2725–2737.
Heydorn WE (2000): Zaleplon — a review of a novel sedative hypnotic used in the treatment of insomnia. Expert Opin Investig Drugs 9: 841–858.
Hohagen F, Rink K, Käppler C, Schramm E, Riemann D, Weyerer S, Berger M (1993): Prevalence and treatment of insomnia in general practice. European Archives of Psychiatry and Clinical Neuroscience 242: 329–336.
Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW (2004): Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med 164: 1888–1896.
Keup W (2004): Zolpidem und Zopiclon. Missbrauchsverschleppung von Benzodiazepin-Derivaten vermeiden. Arzneimitteltherapie 22: 236–238.
Klotz U (1995): Benzodiazepin-Hypnotika; Pharmakokinetik. In: Riederer P, Laux G, Pöldinger W (Hrsg): Neuropsychopharmaka, Bd 2. Springer-Verlag, Wien, S. 135–139.
Lader M (1987): Clinical Pharmacology of Benzodiazepines. Ann Rev Med 38: 19–28.
Lader MH (2001): Implications of hypnotic flexibility on patterns of clinical use. Int J Clin Pract 116(Suppl): 14–19.
Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M (2003): Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomised controlled trial. Br J Gen Pract 53: 923–928.
Perlis ML, McCall WV, Krystal AD, Walsh JK (2004): Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry 65: 1128–1137.
Sateia MJ, Nowell PD (2004): Insomnia. Lancet. 364: 1959–73.
Schenck CH, Mahowald MW, Sack RL (2003): Assessment and management of insomnia. JAMA 289(19): 2475–2479.
Schapira AH (2004): Restless legs syndrome: an update on treatment options. Drugs 64: 149–158.
Simen S, Hajak G, Schlaf G, Westenhöfer J, Rodenbeck A, Bandel B, Pudel V, Rüther E (1995): Chronifizierung von Schlafbeschwerden. Nervenarzt 66: 686–695.
Soyka M, Bottlender R, Möller HJ (2000): Epidemiological evidence for a low abuse potential of zolpidem. Pharmacopsychiatry 33: 138–141.
Swainston Harrison T, Keating GM (2005): Zolpidem: a review of its use in the management of insomnia. CNS Drugs 19: 65–89.
Stocker HR (1967): Sedative und hypnogene Wirkung des Hopfens. Schweiz. Brau.-Rundsch. 78: 80–89.
Terzanomg, Rossi M, Palomba V, Smerieri A, Parrino L (2003): New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 26: 261–282.
Weyerer S, Dilling H (1991): Prevalence and treatment of insomnia in the community: Results from the upper Bavarian field study. Sleep 14: 392–398.
Wiegand MH (2003): Arzneimittelbehandlung von Schlafstörungen im Alter. Internist 44: 1187–1192.
Wortelboer U, Cohrs S, Rodenbeck A, Rüther E (2002): Tolerability of hypnosedatives in older patients. Drugs Aging 19: 529–539.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Lohse, M.J., Müller-Oerlinghausen, B. (2006). Hypnotika und Sedativa. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2005. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30505-X_30
Download citation
DOI: https://doi.org/10.1007/3-540-30505-X_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28368-3
Online ISBN: 978-3-540-30505-7
eBook Packages: Medicine (German Language)